“Exercise is the best antidepressant,” people say — but why it works stayed a black box for a long time. A new study in Molecular Psychiatry names a molecule: apelin, a protein that working muscle releases into the blood. In mice it travels straight to the hippocampus and rolls back depression-like behaviour.
You hear it constantly: move, walk, run — your mood will follow. The advice is sound; clinically, exercise is one of the most reliable antidepressants there is. But for years one question stayed open: what actually passes between the leg and the brain? Which signal crosses the skull?
Jiasui Yu and Suk-Yu Yau of the Hong Kong Polytechnic University propose a name: apelin. It is a “myokine” — a chemical letter that working skeletal muscle releases into the blood. Apelin was known mostly for its links to the heart and to sarcopenia, the muscle loss that comes with age. It turns out it also talks to the brain.
The work was done in mice. To model depression the team used chronic unpredictable stress — days of small, unpredictable disturbances. In the stressed animals, levels of apelin and its receptor, APJ, fell sharply in the hippocampus, the region central to memory and mood.
Then, running. The mice were given four weeks of voluntary access to a running wheel. Depression-like behaviour receded. Apelin rose again in the blood and in the hippocampus. The source of the molecule was clear: the leg muscles — the gastrocnemius and the tibialis anterior.
From there the study moved in two directions. First: is apelin actually necessary? The researchers switched off the apelin gene in skeletal muscle only. The result: running lost its antidepressant effect. Without the protein from the legs, the brain could not collect the benefit.
Second: is apelin enough on its own? This time the mice did not run — their leg muscles were simply engineered to make extra apelin. In stressed animals that almost fully reproduced the effect of running. The benefit of movement, without the movement.
The mechanism reads like this: working muscle releases apelin into the blood; the molecule reaches the brain and binds APJ receptors on glutamatergic neurons in the hippocampus. From there it strengthens signalling through the NMDA receptor and speeds up the birth of new neurons — neurogenesis. These are exactly the processes that weaken in depression.
Here is the inspiring part: the brain is not a sealed organ inside the skull. Every stride your leg takes sends a chemical message. “A sound mind in a sound body” is not only a figure of speech — there is now a measurable biological chain beneath it: muscle, blood, receptor, synapse.
Caution is due. This is a mouse study; the findings cannot be transferred straight to people. It is not a replacement for antidepressant medication. But humans also secrete apelin from working muscle, and the human hippocampus does the same job — the direction is plausible, and now testable.
The authors see a use especially for older people: depression that arrives alongside muscle loss — “sarcopenia-associated depression” — where apelin could be a new drug target. But there is a simpler reading too. Movement is not just advice; it is a measurable mechanism. Next time you take the stairs, it is not only cardio — your leg muscle is saying a word to your brain.
Study: Yu J, Yau S-Y, “How muscle talks to brain: apelin protein mediates exercise-induced antidepressant effects”, Molecular Psychiatry, 2026. nature.com/articles/s41380-026-03651-y